Skip to main content

Advertisement

Log in

Comparison of Pharmacy-Based Measures of Adherence to Antiretroviral Therapy as Predictors of Virological Failure

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

We compared multiple pharmacy refill-based adherence indicators for antiretroviral therapy, as well as thresholds for defining non-adherent behavior, based on ability to predict virological failure. A total of 29,937 pharmacy visits with corresponding viral load assessments were contributed by 8,695 patients attending a large clinic in Johannesburg, South Africa. Indicators based on pill coverage and timing of refill pickup performed comparably using the strictest thresholds for adherence [100 % pill coverage: odds ratio (OR) (95 % confidence interval (CI)) : 1.26 (1.15, 1.39); prescription picked up on or before scheduled refill date: 1.27 (1.16,1.38)]. For both types of indicators, the association between non-adherence and virological failure increased as the threshold defining adherent behavior was lowered. All measures demonstrated high specificity (range 84–98 %), but low sensitivity (5–19 %). In this setting, patients identified as non-adherent using pharmacy-based indicators are likely correctly classified and in need of interventions to improve compliance. Pharmacy based measures alone, however, are inadequate for identifying most cases of nonadherence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. de Garcia Olalla P, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. JAIDS. 2002;30(1):105–10.

    Google Scholar 

  2. Kredo T, Walt J, Siegfried N, Cohen K. Therapeutic drug monitoring of antiretrovirals for people with HIV. Cochrane DB Syst Rev. 2009; 8(3): Article Number CD007268.

  3. Lima V, Harrigan R, Murray M, et al. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS. 2008;22:2371–80.

    Article  PubMed  Google Scholar 

  4. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–60.

    Article  PubMed  Google Scholar 

  5. Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008;197(Suppl 3):S272–8.

    Article  PubMed  Google Scholar 

  6. World Health Organization. Patient monitoring guidelines for HIV care and antiretroviral therapy (ART). Geneva: WHO; 2006.

    Google Scholar 

  7. McMahon JH, Jordan MR, Kelley K, et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis. 2012;52(4):493–506.

    Article  Google Scholar 

  8. Grossberg R, Gross R. Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV/AIDS Rep. 2007;4:187–91.

    Article  PubMed  Google Scholar 

  9. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280–8.

    Article  PubMed  Google Scholar 

  10. Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57:1107–10.

    Article  PubMed  Google Scholar 

  11. Fox M, Maskew M, Macphail AP, et al. Cohort profile: the Themba Lethu Clinical cohort, Johannesburg, South Africa. Int J Epidemiol. 2013;42(2):430–9.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Westreich D, Cole SR, Nagar S, Maskew M, van der Horst C, Sanne I. Pregnancy and virologic response to antiretroviral therapy in South Africa. PLoS ONE. 2011;6(8):e22778.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in Sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90.

    Article  CAS  PubMed  Google Scholar 

  14. Riddler S, Haubrich R, DiRienzo AG, et al. Class-sparing regimens for initial treatment of HIV-1 infection. N Engl J Med. 2008;358(20):2095–106.

    Article  CAS  PubMed  Google Scholar 

  15. Westreich D, Cole SR, Funk MJ, Brookhart MA, Sturmer T. The role of the c-statistic in variable selection for propensity score models. Pharmacoepidemiol Drug Saf. 2011;20(3):317–20.

    Article  PubMed Central  PubMed  Google Scholar 

  16. El-Khatib Z, Ekstrom AM, Coovadia A, et al. Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa- a prospective cohort study. BMC Public Health. 2011;11:88.

    Article  PubMed Central  PubMed  Google Scholar 

  17. El-Khatib Z, Ekstrom AM, Ledwaba J, et al. Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. AIDS. 2010;24:1679–87.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Ross-Degnan D, Pierre-Jacques M, Zhang F, et al. Measuring adherence to antiretroviral treatment in resource -poor settings: the clinical validity of key indicators. BMC Health Serv Res. 2010;10:42.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347:385–94.

    Article  CAS  PubMed  Google Scholar 

  20. Bangsberg DR, Hecht FM, Charlebois ED, Chesney M, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5(3):275–81.

    Article  Google Scholar 

  21. Pepe M, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol. 2004;159(9):882–90.

    Article  PubMed  Google Scholar 

  22. Murphy RA, Sunpath H, Lu Z, et al. Outcomes after virologic failure of first-line ART in South Africa. AIDS. 2010;24(7):1007–12.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Chesney MA. The elusive gold standard: future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S149–55.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors gratefully acknowledge the dedicated staff of the Themba Lethu Clinic and all clinic patients for allowing them to use their clinic data for research purposes. Clinical activities at the Themba Lethu Clinic are supported by the South African National and Gauteng provincial Department of Health, with additional funding support from the United States President’s Emergency Plan for AIDS Relief (PEPFAR) in a Grant by USAID to Right to Care and the Institution (674-A-00-08-00007-00). C.H. and D.W. received funding from the National Institute for Health Grant R00-HD-06-3961.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cassidy E. Henegar.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 19 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Henegar, C.E., Westreich, D., Maskew, M. et al. Comparison of Pharmacy-Based Measures of Adherence to Antiretroviral Therapy as Predictors of Virological Failure. AIDS Behav 19, 612–618 (2015). https://doi.org/10.1007/s10461-014-0953-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-014-0953-2

Keywords

Navigation